BIOHARVEST SCIENCES INC (BHST) Stock Price, Quote, News and Overview
NASDAQ:BHST - Nasdaq - CA09076J2074 - Common Stock - Currency: USD
BHST Quote, Performance and Key Statistics
6.2625
-0.09 (-1.38%)
The current stock price of BHST is 6.2625 USD. In the past month the price decreased by -5.83%.
BHST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| UL | UNILEVER PLC-SPONSORED ADR | 24.18 | 156.64B | ||
| KVUE | KENVUE INC | 21.7 | 45.83B | ||
| EL | ESTEE LAUDER COMPANIES-CL A | 32.65 | 24.08B | ||
| BRBR | BELLRING BRANDS INC | 29.14 | 7.99B | ||
| ELF | ELF BEAUTY INC | 33.18 | 6.34B | ||
| IPAR | INTERPARFUMS INC | 25.85 | 4.38B | ||
| COTY | COTY INC-CL A | 20.54 | 4.30B | ||
| ODD | ODDITY TECH LTD-CL A | 36.67 | 4.16B | ||
| EPC | EDGEWELL PERSONAL CARE CO | 9.59 | 1.30B | ||
| OLPX | OLAPLEX HOLDINGS INC | 16.5 | 879.01M | ||
| HLF | HERBALIFE LTD | 3.79 | 795.45M | ||
| USNA | USANA HEALTH SCIENCES INC | 12.09 | 556.18M |
Related stock screener links
About BHST
Company Profile
BioHarvest Sciences, Inc. develops bio-cell growth platform technology. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2015-08-05. The firm leverages its patented technology process to grow plant-based molecules, without the need to grow the underlying plant. The company is leveraging its botanical synthesis technology to develop the next generation of science-based and clinically proven therapeutic solutions within two business verticals: as a contract development and production organization on behalf of customers seeking complex molecules, and as a creator of nutraceutical health and wellness products, which include dietary supplements. Its segments include Nutraceuticals and Pharmaceuticals. VINIA is a red grape cell-based supplement, which is a commercial nutraceutical product derived from the Botanical Synthesis platform and is clinically proven to improve blood flow, which enhances physical energy and mental alertness. VINIA contains multiple polyphenols, including Piceid Resveratrol, which is 25x more soluble in water than regular resveratrol.
Company Info
BIOHARVEST SCIENCES INC
1140 - 625 Howe Street
Vancouver BRITISH COLUMBIA CA
Employees: 0
Phone: 16046221186
BIOHARVEST SCIENCES INC / BHST FAQ
What is the stock price of BIOHARVEST SCIENCES INC today?
The current stock price of BHST is 6.2625 USD. The price decreased by -1.38% in the last trading session.
What is the ticker symbol for BIOHARVEST SCIENCES INC stock?
The exchange symbol of BIOHARVEST SCIENCES INC is BHST and it is listed on the Nasdaq exchange.
On which exchange is BHST stock listed?
BHST stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for BIOHARVEST SCIENCES INC stock?
8 analysts have analysed BHST and the average price target is 9.3 USD. This implies a price increase of 48.47% is expected in the next year compared to the current price of 6.2625. Check the BIOHARVEST SCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is BIOHARVEST SCIENCES INC worth?
BIOHARVEST SCIENCES INC (BHST) has a market capitalization of 108.53M USD. This makes BHST a Micro Cap stock.
How many employees does BIOHARVEST SCIENCES INC have?
BIOHARVEST SCIENCES INC (BHST) currently has 0 employees.
What are the support and resistance levels for BIOHARVEST SCIENCES INC (BHST) stock?
BIOHARVEST SCIENCES INC (BHST) has a support level at 6.25 and a resistance level at 6.27. Check the full technical report for a detailed analysis of BHST support and resistance levels.
Is BIOHARVEST SCIENCES INC (BHST) expected to grow?
The Revenue of BIOHARVEST SCIENCES INC (BHST) is expected to grow by 161.11% in the next year. Check the estimates tab for more information on the BHST EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy BIOHARVEST SCIENCES INC (BHST) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of BHST, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of BHST, evaluating the profitability, health, valuation and growth aspects
- BIOHARVEST SCIENCES INC (BHST) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- BIOHARVEST SCIENCES INC (BHST) Sales and EPS estimates to see what analysts future expectations are.
- BIOHARVEST SCIENCES INC (BHST) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- BIOHARVEST SCIENCES INC (BHST) Insider and Institutional Ownership to learn about the owners and their transactions.
- BIOHARVEST SCIENCES INC (BHST) Stock Chart to make your own analysis
- BIOHARVEST SCIENCES INC (BHST) Latest news and press-releases to stay up to date.
Does BIOHARVEST SCIENCES INC (BHST) stock pay dividends?
BHST does not pay a dividend.
When does BIOHARVEST SCIENCES INC (BHST) report earnings?
BIOHARVEST SCIENCES INC (BHST) will report earnings on 2025-08-27.
What is the Price/Earnings (PE) ratio of BIOHARVEST SCIENCES INC (BHST)?
BIOHARVEST SCIENCES INC (BHST) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.19).
What is the Short Interest ratio of BIOHARVEST SCIENCES INC (BHST) stock?
The outstanding short interest for BIOHARVEST SCIENCES INC (BHST) is 0.2% of its float. Check the ownership tab for more information on the BHST short interest.
BHST Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to BHST.
BHST Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to BHST. BHST may be in some trouble as it scores bad on both profitability and health.
BHST Financial Highlights
Over the last trailing twelve months BHST reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS decreased by -734.76% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -66.58% | ||
| ROE | -415.37% | ||
| Debt/Equity | 2.58 |
BHST Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to BHST. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of -4% and a revenue growth 161.11% for BHST